Paper9529249
ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways.
Zhang Y and 2 others. Cell, 1998. Cited by 1,369 papers, by iCite.
Cite this record
ConductScience Library. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Papers, record 9529249. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9529249
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Genes, p16 | Major topic |
| Nuclear Proteins | Major topic |
| Proteins | Major topic |
| Proto-Oncogene Proteins | Major topic |
| Retinoblastoma Protein | Major topic |
| Tumor Suppressor Protein p53 | Major topic |
| Cell Division | |
| Exons | |
| Gene Deletion | |
| HeLa Cells | |
| Humans | |
| Mutagenesis | |
| Protein Binding | |
| Proto-Oncogene Proteins c-mdm2 | |
| Tumor Suppressor Protein p14ARF |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| KO8-CA72968 | NCI NIH HHS | United States | K08CA072968 | PubMed and NIH | NIH RePORTER |
| R01-CA65572 | NCI NIH HHS | United States | R01CA065572 | PubMed and NIH | NIH RePORTER |
Cited by613
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,369 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42779730 | Single-cell splice isoform usage reveals distinct axes of cellular identity and senescence. | bioRxiv | 2026 | https://conductscience.org/library/papers/42779730 | PubMed |
| 42707686 | Harnessing Natural Extracellular Vesicles to Combat Age-Related Diseases: From Aging Drivers to Therapeutic Opportunities. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42707686 | PubMed |
| 41959302 | PRMT5 is Frequently Upregulated and a Potential Therapeutic Target in MTAP-deficient Malignant Peripheral Nerve Sheath Tumors. | bioRxiv | 2026 | https://conductscience.org/library/papers/41959302 | PubMed |
| 41939253 | Unraveling the role of TP53 mutations in myeloproliferative neoplasms: Molecular mechanisms of leukemic transformation. | Hemasphere | 2026 | https://conductscience.org/library/papers/41939253 | PubMed |
| 41828605 | Cellular Senescence Triggered by Food and Environmental Genotoxins. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41828605 | PubMed |
| 41811433 | Inactivation of CDKN2AARF Promotes p53-Independent Remodeling of the PDAC Tumor Microenvironment. | Cancer Res | 2026 | https://conductscience.org/library/papers/41811433 | PubMed |
| 41749833 | Burkitt Lymphoma-A Guide to Biological Features, Diagnosis and Differential Diagnosis. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41749833 | PubMed |
| 41649513 | miRNA profiling in pediatric and young adult Burkitt leukemia and lymphoma. | Virchows Arch | 2026 | https://conductscience.org/library/papers/41649513 | PubMed |
| 41339993 | Abnormal nuclear and nucleolar immunoreactivity of p16INK4a represents a frameshift alteration in CDKN2A: the E6H4 clone recognizes the "p14ARF::p16INK4a" chimeric protein. | Virchows Arch | 2025 | https://conductscience.org/library/papers/41339993 | PubMed |
| 41155143 | Targeted Inhibition of Colorectal Carcinoma Using a Designed CEA-Binding Protein to Deliver p53 Protein and TCF/LEF Transcription Factor Decoy DNA. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41155143 | PubMed |
| 40723291 | Novel Therapeutics and the Path Toward Effective Immunotherapy in Malignant Peripheral Nerve Sheath Tumors. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40723291 | PubMed |
| 40334261 | Correlation of p53 oligomeric status and its subcellular localization in the presence of the AML-associated NPM mutant. | PLoS One | 2025 | https://conductscience.org/library/papers/40334261 | PubMed |
| 40019880 | Restoration of angiogenic capacity in senescent endothelial cells by a pharmacological reprogramming approach. | PLoS One | 2025 | https://conductscience.org/library/papers/40019880 | PubMed |
| 40011944 | Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies. | Mol Cancer | 2025 | https://conductscience.org/library/papers/40011944 | PubMed |
| 39827422 | Tumor microenvironment noise-induced polarization: the main challenge in macrophages' immunotherapy for cancer. | Mol Cell Biochem | 2025 | https://conductscience.org/library/papers/39827422 | PubMed |
| 39820247 | Complex p53 dynamics regulated by miR-125b in cellular responses to reactive oxidative stress and DNA damage. | Brief Bioinform | 2024 | https://conductscience.org/library/papers/39820247 | PubMed |
| 39614268 | Mechanisms and cross-talk of regulated cell death and their epigenetic modifications in tumor progression. | Mol Cancer | 2024 | https://conductscience.org/library/papers/39614268 | PubMed |
| 39022644 | Hemizygous deletion of cyclin-dependent kinase inhibitor 2A/B with p16 immuno-negative and methylthioadenosine phosphorylase retention predicts poor prognosis in IDH-mutant adult glioma. | Neurooncol Adv | 2024 | https://conductscience.org/library/papers/39022644 | PubMed |
| 39005671 | Potential roles of UCH family deubiquitinases in tumorigenesis and chemical inhibitors developed against them. | Am J Cancer Res | 2024 | https://conductscience.org/library/papers/39005671 | PubMed |
| 38750022 | The cell cycle regulator p16 promotes tumor infiltrated CD8+ T cell exhaustion and apoptosis. | Cell Death Dis | 2024 | https://conductscience.org/library/papers/38750022 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CDK4 | 1019 | PubTator's text mining | https://conductscience.org/library/genes/1019 | NCBI Gene |
| CDK6 | 1021 | PubTator's text mining | https://conductscience.org/library/genes/1021 | NCBI Gene |
| CDKN2A | 1029 | PubTator's text mining | https://conductscience.org/library/genes/1029 | NCBI Gene |
| MDM2 | 4193 | PubTator's text mining | https://conductscience.org/library/genes/4193 | NCBI Gene |
| RB1 | 5925 | PubTator's text mining | https://conductscience.org/library/genes/5925 | NCBI Gene |
| TBP | 6908 | PubTator's text mining | https://conductscience.org/library/genes/6908 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
| TP53BP1 | 7158 | PubTator's text mining | https://conductscience.org/library/genes/7158 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9529249
GET https://conductscience.org/api/papers/v1/9529249/cited_by?page=2